All media resources and updates in one place.

We prioritise strong media relations to boost our brand visibility and build trust with our audience. Our team engages with journalists and influencers, sharing our innovative approaches and success stories. Transparent communication is essential for lasting relationships, and we keep the media updated on our latest developments.

Recent Updates and Media Releases

CamDiab and mylife Diabetes Care launch a new era in diabetes management

Today, CamDiab and mylife Diabetes Care announce the commercial launch of the CamAPS Liberty feature across key European markets, meaning myLoop, powered by CamAPS FX, becomes the first commercially available fully closed-loop system. Designed to automate insulin delivery without requiring routine bolusing for meals and snacks, this functionality will be made available to patients worldwide via an app update, providing myLoop users with this latest innovation.

mylife Diabetes Care, CamDiab, and Dexcom announce the integration of Dexcom G7 into the myLoop AID system

Expanding choice and adaptive care in automated insulin delivery for people with type 1 diabetes

Same purpose, stronger identity: mylife Diabetes Care takes next step as an independent diabetes care company

The new global identity reflects the company’s purpose and focus, while supporting the transition to mylife Diabetes Care AG as legal manufacturer.

Asian businesswoman checking messages on her mobile phone while leaning against a wall, with a diverse group of busy colleagues collaborating in the background of their modern office

mylife Diabetes Care and Glooko Expand Diabetes Data Management Partnership

Latest agreement supports connected diabetes data management for people using mylife Loop powered by CamAPS FX, as well as their healthcare teams

mylife Diabetes Care and CamDiab introduce the latest innovation from CamDiab: CamAPS Liberty – the first fully closed-loop option within myLoop

CamAPS Liberty is a new feature within the CamAPS FX app for people living with type 1 diabetes, designed to help reduce the daily decision burden and provide greater flexibility, particularly at key moments in their lifelong journey.

Health Canada approves expanded compatibility for myLoop with iOS and Abbott’s FreeStyle Libre 3 Plus Sensor

myLoop powered by CamAPS FX becomes the first automated insulin delivery system in Canada compatible with two glucose monitoring systems for people living with type 1 diabetes.

Press Contact

For any press inquiries, please contact our media relations team at marketing@mylife-diabetescare.com. We are happy to assist with any questions or requests and provide you with the information you need.